ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05033	Nicotine addiction	8/83	56/7206	1.99559559951e-07
ko04724	Glutamatergic synapse	11/83	152/7206	1.12040504843e-06
ko04728	Dopaminergic synapse	12/83	185/7206	1.13187652986e-06
ko05031	Amphetamine addiction	6/83	91/7206	0.000594322020939
ko05014	Amyotrophic lateral sclerosis (ALS)	5/83	74/7206	0.00155242559257
ko04010	MAPK signaling pathway	10/83	321/7206	0.00360810668099
ko04360	Axon guidance	8/83	233/7206	0.00517685517221
ko00604	Glycosphingolipid biosynthesis - ganglio series	2/83	14/7206	0.0109037627555
ko04721	Synaptic vesicle cycle	4/83	80/7206	0.0133428107268
ko04723	Retrograde endocannabinoid signaling	6/83	175/7206	0.0152007022574
ko04720	Long-term potentiation	4/83	99/7206	0.0269734791926
ko00515	Mannose type O-glycan biosynthesis	2/83	25/7206	0.0331311680927
ko05213	Endometrial cancer	3/83	62/7206	0.0342630690009
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	2/83	28/7206	0.0408326663062